Profound Medical (PROF) Cash from Financing Activities (2018 - 2025)
Profound Medical's quarterly Cash from Financing Activities came in at $41.4 million in Q4 2025, up 16.91% year-on-year from $35.4 million in Q4 2024, and up 14385.52% quarter-over-quarter from -$290000.0 in Q1 2025.
Profound Medical has reported Cash from Financing Activities for 8 years, with the latest figure at $41.4 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 16.91% year-over-year to $41.4 million; the trailing twelve-month figure through Dec 2025 stood at $41.1 million (down 24.79% YoY), and the FY2025 full-year result was $41.1 million, down 24.79% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $41.4 million, up from -$290000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $41.4 million in Q4 2025, with the low at -$603000.0 in Q2 2024.
- Average Cash from Financing Activities over 5 years is $6.5 million, with a median of $89000.0 recorded in 2022.
- Year-over-year, Cash from Financing Activities tumbled 312.36% in 2023 and jumped 17906.53% in 2024.
- Tracing PROF's Cash from Financing Activities over 5 years: stood at -$88000.0 in 2021, then jumped by 8063.64% to $7.0 million in 2022, then tumbled by 102.84% to -$199000.0 in 2023, then jumped by 17906.53% to $35.4 million in 2024, then rose by 16.91% to $41.4 million in 2025.
- The last three Cash from Financing Activities figures came in at $41.4 million (Q4 2025), -$290000.0 (Q1 2025), and $35.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.43 Mn |
| Dec 31, 2025 | 41.43 Mn |
| Mar 31, 2025 | -290,000.00 |
| Mar 31, 2025 | -290,000.00 |
| Dec 31, 2024 | 35.44 Mn |
| Dec 31, 2024 | 35.44 Mn |
| Sep 30, 2024 | -592,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Mar 31, 2024 | 20.46 Mn |
| Mar 31, 2024 | 20.46 Mn |
| Dec 31, 2023 | -199,000.00 |
| Dec 31, 2023 | -199,000.00 |
| Sep 30, 2023 | -189,000.00 |
| Sep 30, 2023 | -189,000.00 |
| Mar 31, 2023 | 2.14 Mn |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 7.01 Mn |
| Dec 31, 2022 | 7.01 Mn |
| Sep 30, 2022 | 89,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | -75,000.00 |
| Mar 31, 2022 | -75,000.00 |
| Dec 31, 2021 | -88,000.00 |
| Dec 31, 2021 | -88,000.00 |
| Sep 30, 2021 | 4.48 Mn |
| Sep 30, 2021 | 4.48 Mn |
| Jun 30, 2021 | 962,000.00 |
| Jun 30, 2021 | 962,000.00 |
| Mar 31, 2021 | 1.20 Mn |
| Mar 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 6.97 Mn |
| Dec 31, 2020 | 6.97 Mn |
| Sep 30, 2020 | 46.22 Mn |
| Sep 30, 2020 | 46.22 Mn |
| Jun 30, 2020 | 608,489.00 |
| Jun 30, 2020 | 608,489.00 |
| Mar 31, 2020 | 34.78 Mn |
| Mar 31, 2020 | 34.78 Mn |
| Dec 31, 2019 | -608,898.39 |
| Dec 31, 2019 | -608,898.39 |
| Sep 30, 2019 | 7.81 Mn |
| Sep 30, 2019 | 7.81 Mn |
| Jun 30, 2019 | -201,164.57 |
| Jun 30, 2019 | -201,164.57 |
| Mar 31, 2019 | -316,043.10 |
| Mar 31, 2019 | -316,043.10 |
| Dec 31, 2018 | -117,223.48 |
| Dec 31, 2018 | -117,223.48 |